Cargando…

Search for antisickling agents from plants

The sickle cell disease is fatal in nature. Thousands of children are dying off due to this health problem throughout the globe. Due to the rapid development of diagnosis and clinical managements such patients are living up to a respectable age. But as there is no permanent cure the patients are suf...

Descripción completa

Detalles Bibliográficos
Autores principales: Dash, Bisnu Prasad, Archana, Y., Satapathy, Nibarana, Naik, Soumendra Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3731880/
https://www.ncbi.nlm.nih.gov/pubmed/23922457
http://dx.doi.org/10.4103/0973-7847.112849
_version_ 1782279216188882944
author Dash, Bisnu Prasad
Archana, Y.
Satapathy, Nibarana
Naik, Soumendra Kumar
author_facet Dash, Bisnu Prasad
Archana, Y.
Satapathy, Nibarana
Naik, Soumendra Kumar
author_sort Dash, Bisnu Prasad
collection PubMed
description The sickle cell disease is fatal in nature. Thousands of children are dying off due to this health problem throughout the globe. Due to the rapid development of diagnosis and clinical managements such patients are living up to a respectable age. But as there is no permanent cure the patients are suffering from bone and joint pain, jaundice, hepato-splenomegaly, chronic infections etc. The main physiological complicacy is due to the polymerization of sickle hemoglobin (HbS), (sickling process) inside the red blood cell (RBC) of these patients during deoxygenating state. The change of RBC from spherical to sickle shape is due to the polymerization of mutant hemoglobin (HbS) inside the RBC and membrane distortion during anoxic condition. The mechanism and the process of sickling are very complex and multifactor in nature. To get rid from such complicacies it is necessary to suitably and accurately stop the sickling of RBC of the patients. The potential anti-sickling agents either from natural sources and/or synthetic molecules may be helpful for reducing the clinical morbidity of the patients. A lot of natural compounds from plant extracts have been tried by several workers in recent past. Most of the studies are based on in vitro red cell sickling studies and their mode of action has not been properly understood. Although, few studies have been in vivo in nature pertaining to transgenic sickle animal model, there is paucity of data on the human studies. The result of such studies although has shown some degree of success, a promising anti-sickling agent is yet to be established.
format Online
Article
Text
id pubmed-3731880
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-37318802013-08-06 Search for antisickling agents from plants Dash, Bisnu Prasad Archana, Y. Satapathy, Nibarana Naik, Soumendra Kumar Pharmacogn Rev Review Article The sickle cell disease is fatal in nature. Thousands of children are dying off due to this health problem throughout the globe. Due to the rapid development of diagnosis and clinical managements such patients are living up to a respectable age. But as there is no permanent cure the patients are suffering from bone and joint pain, jaundice, hepato-splenomegaly, chronic infections etc. The main physiological complicacy is due to the polymerization of sickle hemoglobin (HbS), (sickling process) inside the red blood cell (RBC) of these patients during deoxygenating state. The change of RBC from spherical to sickle shape is due to the polymerization of mutant hemoglobin (HbS) inside the RBC and membrane distortion during anoxic condition. The mechanism and the process of sickling are very complex and multifactor in nature. To get rid from such complicacies it is necessary to suitably and accurately stop the sickling of RBC of the patients. The potential anti-sickling agents either from natural sources and/or synthetic molecules may be helpful for reducing the clinical morbidity of the patients. A lot of natural compounds from plant extracts have been tried by several workers in recent past. Most of the studies are based on in vitro red cell sickling studies and their mode of action has not been properly understood. Although, few studies have been in vivo in nature pertaining to transgenic sickle animal model, there is paucity of data on the human studies. The result of such studies although has shown some degree of success, a promising anti-sickling agent is yet to be established. Medknow Publications & Media Pvt Ltd 2013 /pmc/articles/PMC3731880/ /pubmed/23922457 http://dx.doi.org/10.4103/0973-7847.112849 Text en Copyright: © Pharmacognosy Reviews http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Dash, Bisnu Prasad
Archana, Y.
Satapathy, Nibarana
Naik, Soumendra Kumar
Search for antisickling agents from plants
title Search for antisickling agents from plants
title_full Search for antisickling agents from plants
title_fullStr Search for antisickling agents from plants
title_full_unstemmed Search for antisickling agents from plants
title_short Search for antisickling agents from plants
title_sort search for antisickling agents from plants
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3731880/
https://www.ncbi.nlm.nih.gov/pubmed/23922457
http://dx.doi.org/10.4103/0973-7847.112849
work_keys_str_mv AT dashbisnuprasad searchforantisicklingagentsfromplants
AT archanay searchforantisicklingagentsfromplants
AT satapathynibarana searchforantisicklingagentsfromplants
AT naiksoumendrakumar searchforantisicklingagentsfromplants